Submit Deal

Submit Deal

Cover Image Kevin Hern

Kevin Hern

Investors Relations Director at ELI LILLY AND COMPANY

Manager

Deal Bio

Total Deals5

Valued Deals5

Total Value£ 3.64 B

Avg. Deal Size£ 729 M

Market Context

Sort

10 May 2018|United States|Pharmaceuticals

Target: ARMO BIOSCIENCES

Bidder: ELI LILLY AND COMPANY

4 Service Providers

2 Target | 2 Bidder

7 Dealmakers

3 Target | 4 Bidder

£ 1.20 B

Value

10 Jan 2020|United States|Pharmaceuticals

Target: DERMIRA INC

Bidder: ELI LILLY AND COMPANY

8 Service Providers

5 Target | 3 Bidder

41 Dealmakers

26 Target | 16 Bidder

£ 838 M

Value

15 Oct 2020|United States|Biotechnology

Target: DISARM THERAPEUTICS

Bidder: ELI LILLY AND COMPANY

5 Service Providers

4 Target | 1 Bidder

7 Dealmakers

2 Target | 5 Bidder

£ 103 M

Value

15 Dec 2020|United States|Biotechnology

Target: PREVAIL THERAPEUTICS

Bidder: ELI LILLY AND COMPANY

11 Service Providers

6 Target | 3 Bidder | 2 Vendor

36 Dealmakers

18 Target | 15 Bidder | 3 Vendor

£ 778 M

Value

14 Jul 2021|United States|Biotechnology

Target: PROTOMER TECHNOLOGIES

Bidder: ELI LILLY AND COMPANY

5 Service Providers

3 Target | 2 Bidder

16 Dealmakers

6 Target | 10 Bidder

£ 722 M

Value

Privacy Policy Terms of Service Contact Us Cookie Preferences

All rights reserved. Copyright © 2025 Datasite